Next Phase Newsletter

By Greg Mannix, VP, EMEA Business Development, LSN

On September 24th, 2024, Life Science Nation (LSN) is offering an exclusive opportunity for RESI Boston attendees and other international companies in Boston that week to gain invaluable insights into the world-renowned Boston-Cambridge life science hub. This free, pre-conference event, titled “Landing Your Company in the Boston Life Science Ecosystem,” is specifically designed to help companies tap into the resources of this thriving ecosystem and establish a strong presence in the US market. Space is limited and registrations will be accepted on a first come, first serve basis.

Event Details

• Date and Time: September 24th, 2024, 9:00 AM – 4:00 PM
• Location: CIC Cambridge, 5th Floor, One Broadway, Cambridge, MA
• Cost: Free for RESI Boston attendees and other international companies in Boston during Boston Biotech Week – Sign Up Here

For more information please contact us at RESI@LifeScienceNation.com.

The day will conclude with a networking reception, providing an excellent opportunity for participants to connect with industry leaders, potential partners, and fellow innovators.

Attending this informative session will allow participants to gain firsthand insights from key players in the Boston-Cambridge life science ecosystem. Experts will share their knowledge about what makes this area unique and how companies can effectively leverage their resources for growth and success.

For international companies looking to establish a presence in the United States, this event is particularly valuable. It offers crucial information on entering the US life science market through one of its most prominent hubs. Attendees will learn how to navigate the landscape, optimize resources, and tap into the vast opportunities available in the Boston-Cambridge area.

The Boston-Cambridge region is globally recognized as a powerhouse in life sciences, characterized by a dense concentration of world-class research institutions and hospitals, a robust network of venture capital firms and investors, and access to top-tier talent from renowned universities. The collaborative ecosystem here fosters innovation and growth, making it an ideal environment for companies at all stages of development.

This pre-RESI event is an excellent opportunity to kickstart your experience at RESI Boston with valuable insights into one of the world’s most dynamic life science ecosystems. For more information or to register, please contact resi@lifesciencenation.com. Don’t miss out on this chance to elevate your company’s presence in the thriving Boston life science community!

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

In the ever-evolving landscape of life sciences, fundraising is not just an option; it’s a necessity. CEOs in this sector must navigate a complex environment where access to capital can define the trajectory of their innovations. One of the most effective strategies for maximizing fundraising success is participating in global events that bring together key investors and decision-makers. The Redefining Early Stage Investments (RESI) events are premier platforms for life science startups. With RESI Boston on September 25, RESI London on December 4, and RESI JPM on January 14, 2025, this series presents a unique opportunity for CEOs.

The Importance of Global Reach

In the life sciences, the competition for funding is fierce, and operating within a confined regional market can limit opportunities. By expanding your search beyond local investors and tapping into the global arena, you significantly increase your chances of finding the right fit for your stage of development and innovative products. The RESI events are strategically designed to allow CEOs to engage with a diverse spectrum of investors from various geographic locations.

Attending both the Boston and London events and culminating with JPM in January allows you to cover critical markets—the East Coast of the U.S., Europe, and the West Coast—all within five months. This geographical breadth means you can connect with 50-60 qualified investors actively seeking investment opportunities in early-stage life sciences, increasing your chances of success.

Fundraising as a Numbers Game

At its core, fundraising is indeed a numbers game. The more potential investors you meet, the higher the likelihood of securing funding. The RESI events are structured to make sure you engage your outreach. With each event attracting a fresh group of investors, your networking efforts compound over time. This is unlike traditional fundraising approaches, where outreach may be static or limited to a single region.

Life Science Nation, the owner of RESI, has a proven track record of delivering diverse investors, ranging from angels and family offices to venture capitalists, private equity firms, and industry-specific players such as pharmaceutical and med tech investors. These investors increasingly leverage LSN’s global events to source new technology assets for their portfolios and product pipelines.

A Unique Lineup of Investors

The alignment of these three events within such a short period extends your reach and introduces you to an audience of investors tailored to your specific needs. The unique lineup of seasoned professionals at these events is precisely what early-stage companies require. This carefully curated access can distinguish between a successful fundraising round and an uphill battle.

CEOs in the life sciences sector must take advantage of the opportunities presented by the RESI events. Engaging with a global network increases visibility and access to critical funding sources. The following five months could very well determine the future trajectory of your company; make it count by attending RESI Boston, RESI London, and RESI JPM. The world of life science investment is waiting, and your next significant opportunity might be one conference away. Don’t miss your chance to take your innovations to the next level!